New insights into protease-activated receptor 4 signaling pathways in the pathogenesis of inflammation and neuropathic pain:A literature review

Channels

Volumn 9, Issue 1, 2015, Pages 5-13

  Bao, Yanju ^a   Gao, Yebo ^a,b   Yang, Liping ^a   Kong, Xiangying ^a   Zheng, Honggang ^a   Hou, Wei ^a   Hua, Baojin ^a  

^a INSTITUTE OF CHINESE MATERIA MEDICA   (China)

^b BEIJING UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Inflammation pain; Neuropathic pain; Protease activated receptor 4

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; CALCIUM ION; KININ; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEINASE ACTIVATED RECEPTOR 4; SUBSTANCE P; TISSUE KALLIKREIN; VANILLOID RECEPTOR 1; PROTEASE-ACTIVATED RECEPTOR 4; THROMBIN RECEPTOR;

CALCIUM CELL LEVEL; CHRONIC PAIN; ENZYME ACTIVATION; HUMAN; HYPERSENSITIVITY; INFLAMMATORY PAIN; INTRACELLULAR SIGNALING; KALLIKREIN KININ SYSTEM; MEDICAL LITERATURE; NERVE INJURY; NEUROGENIC INFLAMMATION; NEUROPATHIC PAIN; NEUROPATHOLOGY; NONHUMAN; PAIN THRESHOLD; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; REVIEW; SENSORY NERVE CELL; SPINAL CORD DORSAL HORN; SPINAL CORD NERVE CELL; SPINAL GANGLION; ANIMAL; INFLAMMATION; METABOLISM; NEURALGIA; SIGNAL TRANSDUCTION;

ANIMALS; HUMANS; INFLAMMATION; NEURALGIA; RECEPTORS, THROMBIN; SIGNAL TRANSDUCTION;

EID: 84923549198     PISSN: 19336950     EISSN: 19336969     Source Type: Journal    
DOI: 10.4161/19336950.2014.995001     Document Type: Review

References (120)

1. Vu TK, Wheaton VI, Hung DT, Charo I, Coughlin SR. Domains specifying thrombin-receptor interaction. Nature 1991; 353:674-;7; PMID:1717851; http://dx.doi.org/10.1038/353674a0
2. Vergnolle N, Bunnett NW, Sharkey KA, Brussee V, Compton SJ, Grady EF, Cirino G, Gerard N, Basbaum AI, Andrade-Gordon P, et al. Proteinase-activated receptor-2 and hyperalgesia: A novel pain pathway. Nat Med 2001; 7:821-6; PMID:11433347; http://dx.doi.org/10.1038/89945
3. Coughlin SR. How the protease thrombin talks to cells. Proc Natl Acad Sci U S A 1999; 96:11023-7; PMID:10500117
4. Hollenberg MD, Compton SJ. International Union of Pharmacology. XXVIII. Proteinase-activated receptors. Pharmacol Rev 2002; 54:203-17; PMID:12037136; http://dx.doi.org/10.1124/ pr.54.2.203
5. Kawabata A, Saifeddine M, al-Ani B, Hollenberg MD. Protease-activated receptors: development of agonists selective for receptors triggered by either thrombin (PAR1) or trypsin (PAR2). Proce West Pharmacol Soc 1997; 40:49-51; PMID:9436211
6. Corvera CU, Dery O, McConalogue K, Bohm SK, Khitin LM, Caughey GH, Payan DG, Bunnett NW. Mast cell tryptase regulates rat colonic myocytes through proteinase-activated receptor 2. J Clin Invest 1997; 100:1383-93; PMID:9294103; http://dx.doi. org/10.1172/JCI119658
7. Molino M, WoolkalisMJ, Reavey-Cantwell J, Pratico D, Andrade-Gordon P, Barnathan ES, Brass LF. Endothelial cell thrombin receptors and PAR-2. Two protease-activated receptors located in a single cellular environment. J Biol Chem 1997; 272:11133-41; PMID:9111010; http://dx.doi.org/10.1074/jbc.272.17.11133
8. Knecht W, Cottrell GS, Amadesi S, Mohlin J, Skaregarde A, Gedda K, Peterson A, Chapman K,Hollenberg MD, Vergnolle N, et al. Trypsin IV or mesotrypsin and p23 cleave protease-activated receptors 1 and 2 to induce inflammation and hyperalgesia. J Biol Chem 2007; 282:26089-100; PMID:17623652; http://dx.doi.org/ 10.1074/jbc.M703840200
9. Kahn ML, Nakanishi-Matsui M, Shapiro MJ, Ishihara H, Coughlin SR. Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin. J Clin Invest 1999; 103:879-87; PMID:10079109; http://dx.doi.org/10.1172/JCI6042
10. Sambrano GR, Huang W, Faruqi T, Mahrus S, Craik C, Coughlin SR. Cathepsin G activates protease-activated receptor-4 in human platelets. J Biol Chem 2000; 275:6819-23; PMID:10702240; http://dx.doi. org/10.1074/jbc.275.10.6819
11. Ramachandran R, Hollenberg MD. Proteinases and signalling: pathophysiological and therapeutic implications via PARs and more. Br J Pharmacol 2008; 153(Suppl 1):S263-82; PMID:18059329
12. Donovan FM, Pike CJ, Cotman CW, Cunningham DD. Thrombin induces apoptosis in cultured neurons and astrocytes via a pathway requiring tyrosine kinase and RhoA activities. J Neurosci 1997; 17:5316-26; PMID:9204916
13. Dugina TN, Kiseleva EV, Lange MA, Vasil'eva TV, Grandfils C, Markvicheva EA, Bespalova ZHD, Pal'keeva ME, Strukova SM. Effect of synthetic peptide thrombin receptor agonist encapsulated in microparticles based on lactic and glycolic acid copolymer on healing of experimental skin wounds in mice. Bull Exp Biol Med 2004; 138:463-6; PMID:15723127; http://dx.doi.org/10.1007/s10517-005-0071-2
14. Patwardhan AM, Diogenes A, Berg KA, Fehrenbacher JC, Clarke WP, Akopian AN, Hargreaves KM. PAR-2 agonists activate trigeminal nociceptors and induce functional competence in the delta opioid receptor. Pain 2006; 125:114-24; PMID:16781076; http://dx. doi.org/10.1016/j.pain.2006.05.007
15. Dai Y, Moriyama T, Higashi T, Togashi K, Kobayashi K, Yamanaka H, Tominaga M, Noguchi K. Pro-teinase-activated receptor 2-mediated potentiation of transient receptor potential vanilloid subfamily 1 activity reveals a mechanism for proteinase-induced inflammatory pain. J Neurosci 2004; 24:4293-9; PMID:15128843; http://dx.doi.org/10.1523/JNEUR OSCI.0454-04.2004
16. Asfaha S, Cenac N, Houle S, Altier C, Papez MD, Nguyen C, Steinhoff M, Chapman K, Zamponi GW, Vergnolle N. Protease-activated receptor-4: a novel mechanism of inflammatory pain modulation. Br J Pharmacol 2007; 150:176-85; PMID:17179954; http://dx.doi.org/10.1038/sj.bjp.0706975
17. Hollenberg MD, Saifeddine M, Sandhu S, Houle S, Vergnolle N. Proteinase-activated receptor-4: evaluation of tethered ligand-derived peptides as probes for receptor function and as inflammatory agonists in vivo. Br J Pharmacol 2004; 143:443-54; PMID:15451771; http://dx.doi.org/10.1038/sj. bjp.0705946
18. Houle S, Papez MD, Ferazzini M, Hollenberg MD, Vergnolle N. Neutrophils and the kallikrein-kinin system in proteinase-activated receptor 4-mediated inflammation in rodents. Br J Pharmacol 2005; 146:670-8; PMID:16100525; http://dx.doi.org/ 10.1038/sj.bjp.0706371
19. McDougall JJ, Zhang C, Cellars L, Joubert E, Dixon CM, Vergnolle N. Triggering of proteinase-activated receptor 4 leads to joint pain and inflammation in mice. Arthritis Rheum 2009; 60:728-37; PMID:19248120; http://dx.doi.org/10.1002/art.24300
20. Vergnolle N, Derian CK, D'Andrea MR, Steinhoff M, Andrade-Gordon P. Characterization of throm-bin-induced leukocyte rolling and adherence: a potential proinflammatory role for proteinase-activated receptor-4. J Immunol 2002; 169:1467-73; PMID:12133973; http://dx.doi.org/10.4049/ jimmunol.169.3.1467
21. Cenac N, Vergnolle N. Proteases and protease-activated receptors (PARs): novel signals for pain. Curr Top Med Chem 2005; 5:569-76; PMID:16022679; http://dx.doi.org/10.2174/1568026054367601
22. Steinhoff M, Vergnolle N, Young SH, Tognetto M, Amadesi S, Ennes HS, Trevisani M, Hollenberg MD, Wallace JL, Caughey GH, et al. Agonists of protein-ase-activated receptor 2 induce inflammation by a neurogenic mechanism. Nat Med 2000; 6:151-8; PMID:10655102; http://dx.doi.org/10.1038/72247
23. de Garavilla L, Vergnolle N, Young SH, Ennes H, Steinhoff M, Ossovskaya VS, D'Andrea MR, Mayer EA, Wallace JL, Hollenberg MD, et al. Agonists of proteinase-activated receptor 1 induce plasma extravasation by a neurogenic mechanism. Br J Pharmacol 2001; 133:975-87; PMID:11487506; http://dx.doi. org/10.1038/sj.bjp.0704152
24. Asfaha S, Brussee V, Chapman K, Zochodne DW, Vergnolle N. Proteinase-activated receptor-1 agonists attenuate nociception in response to noxious stimuli. Br J Pharmacol 2002; 135:1101-6; PMID:11877315; http://dx.doi.org/10.1038/sj.bjp.0704568
25. D'Andrea MR, Saban MR, Nguyen NB, Andrade-Gordon P, Saban R. Expression of protease-activated receptor-1, -2, -3, and -;4 in control and experimentally inflamed mouse bladder. Am J Pathol 2003; 162:907-23; PMID:12598324; http://dx.doi.org/ 10.1016/S0002-9440(10)63886-2
26. Bulling DG, Kelly D, Bond S, McQueen DS, Seckl JR. Adjuvant-induced joint inflammation causes very rapid transcription of beta-preprotachykinin and alpha-CGRP genes in innervating sensory ganglia. J Neurochem 2001; 77:372-82; PMID:11299299; http://dx.doi.org/10.1046/j.1471-4159.2001.00175.x
27. Ambalavanar R, Dessem D, Moutanni A, Yallampalli C, Yallampalli U, Gangula P, Bai G. Muscle inflammation induces a rapid increase in calcitonin generelated peptide (CGRP) mRNA that temporally relates to CGRP immunoreactivity and nociceptive behavior. Neuroscience 2006; 143:875-84; PMID:17027165; http://dx.doi.org/10.1016/j. neuroscience.2006.08.015
28. Xu X,Wang P, Zou X, LiD, Fang L, LinQ. Increases in transient receptor potential vanilloid-1 mRNA and protein in primary afferent neurons stimulated by protein kinase C and their possible role in neurogenic inflammation. J Neurosci Res 2009; 87:482-94; PMID:18752301; http://dx.doi.org/10.1002/jnr.21844
29. Dattilio A, Vizzard MA. Up-regulation of protease activated receptors in bladder after cyclophosphamide induced cystitis and colocalization with capsaicin receptor (VR1) in bladder nerve fibers. J Urol 2005; 173:635-9; PMID:15643279; http://dx.doi.org/ 10.1097/01.ju.0000143191.55468.1d
30. Benemei S, Nicoletti P, Capone JG, Geppetti P. CGRP receptors in the control of pain and inflammation. Curr Opin Pharmacol 2009; 9:9-14; PMID:19157980; http://dx.doi.org/10.1016/j.coph.2008.12.007
31. Chen D, Wang Z, Zhang Z, Zhang R, Yu L. Capsaicin up-regulates protease-activated receptor-4 mRNA and protein in primary cultured dorsal root ganglion neurons. Cell Mol Neurobiol 2013; 33:337-46; PMID:23274964; http://dx.doi.org/10.1007/s10571-012-9899-y
32. Wang Z, Chen D, Zhang Z, Zhang R, An S, Yu L. Protease-activated receptor 4 activation increases the expression of calcitonin gene-related peptide mRNA and protein in dorsal root ganglion neurons. J Neurosci Res 2013; 91:1551-62; PMID:24105611; http:// dx.doi.org/10.1002/jnr.23280
33. Vellani V, Kinsey AM, Prandini M, Hechtfischer SC, Reeh P, Magherini PC, Giacomoni C, McNaughton PA. Protease activated receptors 1 and 4 sensitize TRPV1 in nociceptive neurones. Mol Pain 2010; 6:61; PMID:20875131; http://dx.doi.org/10.1186/ 1744-8069-6-61
34. Young SE, Duvernay MT, Schulte ML, Lindsley CW, Hamm HE. Synthesis of indole derived protease-activated receptor 4 antagonists and characterization in human platelets. PloS One 2013; 8:e65528; PMID:23776495
35. th edition. Br J Pharmacol 2011; 164(Suppl 1):S1-324; PMID:NOT-FOUND; http://dx.doi.org/10.1111/j.1476-5381.2011.01649-1.x
36. Leger AJ, Covic L, Kuliopulos A. Protease-activated receptors in cardiovascular diseases. Circulation 2006; 114:1070-7; PMID:16952995; http://dx.doi.org/ 10.1161/CIRCULATIONAHA.105.574830
37. Coughlin SR. Protease-activated receptors in hemostasis, thrombosis and vascular biology. J Thromb Haemost 2005; 3:1800-14; PMID:16102047
38. Murugappan S, Shankar H, Bhamidipati S, Dorsam RT, Jin J, Kunapuli SP. Molecular mechanism and functional implications of thrombin-mediated tyrosine phosphorylation of PKCdelta in platelets. Blood 2005; 106:550-7; PMID:15811957; http://dx.doi. org/10.1182/blood-2004-12-4866
39. Hundle B, McMahon T, Dadgar J, Messing RO. Overexpression of epsilon-protein kinase C enhances nerve growth factor-induced phosphorylation of mito-gen-activated protein kinases and neurite outgrowth. J Biol Chem 1995; 270:30134-40; PMID:8530420; http://dx.doi.org/10.1074/jbc.270.50.30134
40. Hundle B, McMahon T, Dadgar J, Chen CH, Mochly-Rosen D, Messing RO. An inhibitory fragment derived from protein kinase Cepsilon prevents enhancement of nerve growth factor responses by ethanol and phorbol esters. J Biol Chem 1997; 272:15028-35; PMID:9169479; http://dx.doi.org/ 10.1074/jbc.272.23.15028
41. Brodie C, Bogi K, Acs P, Lazarovici P, Petrovics G, Anderson WB, Blumberg PM. Protein kinase C-epsilon plays a role in neurite outgrowth in response to epidermal growth factor and nerve growth factor in PC12 cells. Cell Growth Differ 1999; 10:183-91; PMID:10099832
42. Megyeri M, Mako V, Beinrohr L, Doleschall Z, Prohaszka Z, Cervenak L, Závodszky P, Gál P. Complement protease MASP-1 activates human endothelial cells: PAR4 activation is a link between complement and endothelial function. J Immunol 2009; 183:3409-16; PMID:19667088; http://dx.doi.org/ 10.4049/jimmunol.0900879
43. Coughlin SR. Thrombin signalling and protease-activated receptors. Nature 2000; 407:258-64; PMID:11001069
44. Momota F, Hirano K, Hirano M, Nishimura J, Kanaide H. Involvement of Gi/o in the PAR-4-induced NO production in endothelial cells. Biochem Biophys Res Commun 2006; 342:365-71; PMID:16483540; http://dx.doi.org/10.1016/j.bbrc. 2006.01.165
45. Hirano K, Nomoto N, Hirano M, Momota F, Hanada A, Kanaide H. Distinct Ca2+ requirement for NO production between proteinase-activated receptor 1 and 4 (PAR1 and PAR4) in vascular endothelial cells. J Pharmacol Exp Ther 2007; 322:668-77; PMID:17494865; http://dx.doi.org/10.1124/jpet. 107.121038
46. Sabri A, Guo J, Elouardighi H, Darrow AL, Andrade-Gordon P, Steinberg SF. Mechanisms of proteaseactivated receptor-4 actions in cardiomyocytes. Role of Src tyrosine kinase. J Biol Chem 2003; 278:11714-20; PMID:12522105; http://dx.doi.org/10.1074/jbc. M213091200
47. Ji RR, Samad TA, Jin SX, Schmoll R, Woolf CJ. p38 MAPK activation by NGF in primary sensory neurons after inflammation increases TRPV1 levels and maintains heat hyperalgesia. Neuron 2002; 36:57-68; PMID:12367506; http://dx.doi.org/10.1016/S0896-6273(02)00908-X
48. Kumar S, Boehm J, Lee JC. p38 MAP kinases: key signallingmolecules as therapeutic targets for inflammatory diseases. Nat Rev Drug Dis 2003; 2:717-26; PMID:12951578; http://dx.doi.org/10.1038/nrd1177
49. Auge C, Balz-Hara D, Steinhoff M, Vergnolle N, Cenac N. Protease-activated receptor-4 (PAR 4): a role as inhibitor of visceral pain and hypersensitivity. Neurogastroenterol Motil 2009; 21:1189-e107; PMID:19413681; http://dx.doi.org/10.1111/j.1365-2982.2009.01310.x
50. Karanjia R, Spreadbury I, Bautista-Cruz F, Tsang ME, Vanner S. Activation of protease-activated recep-tor-4 inhibits the intrinsic excitability of colonic dorsal root ganglia neurons. Neurogastroenterol Motil 2009; 21:1218-21; PMID:19566587; http://dx.doi.org/ 10.1111/j.1365-2982.2009.01353.x
51. Ji RR, Woolf CJ. Neuronal plasticity and signal transduction in nociceptive neurons: implications for the initiation and maintenance of pathological pain. Neurobiol Dis 2001; 8:1-10; PMID:11162235; http://dx. doi.org/10.1006/nbdi.2000.0360
52. Aley KO, Martin A, McMahon T, Mok J, Levine JD, Messing RO. Nociceptor sensitization by extracellular signal-regulated kinases. J Neurosci 2001; 21:6933-9; PMID:11517280
53. Ohtsuka T, Shimizu K, Yamamori B, Kuroda S, Takai Y. Activation of brain B-Raf protein kinase by Rap1B small GTP-binding protein. J Biol Chem 1996; 271:1258-61; PMID:8576107; http://dx.doi.org/ 10.1074/jbc.271.3.1258
54. Vossler MR, Yao H, York RD, Pan MG, Rim CS, Stork PJ. cAMP activates MAP kinase and Elk-1 through a B-Raf- and Rap1-dependent pathway. Cell 1997; 89:73-82; PMID:9094716; http://dx.doi.org/ 10.1016/S0092-8674(00)80184-1
55. Kawasaki H, Springett GM, Mochizuki N, Toki S, Nakaya M, Matsuda M, Housman DE, Graybiel AM. A family of cAMP-binding proteins that directly activate Rap1. Science 1998; 282:2275-9; PMID:9856955; http://dx.doi.org/10.1126/science. 282.5397.2275
56. York RD, Yao H, Dillon T, Ellig CL, Eckert SP, McCleskey EW, Stork PJ. Rap1 mediates sustained MAP kinase activation induced by nerve growth factor. Nature 1998; 392:622-6; PMID:9560161; http://dx.doi.org/10.1038/33451
57. Posas F, TakekawaM, Saito H. Signal transduction by MAP kinase cascades in budding yeast. Curr Opin Microbiol 1998; 1:175-82; PMID:10066475; http:// dx.doi.org/10.1016/S1369-5274(98)80008-8
58. Ma W, Quirion R. The ERK/MAPK pathway, as a target for the treatment of neuropathic pain. Expert Opin Ther Targets 2005; 9:699-713; PMID:16083338; http://dx.doi.org/10.1517/14728222.9.4.699
59. Ji RR, Gereau RW 4th, Malcangio M, Strichartz GR. MAP kinase and pain. Brain Res Rev 2009; 60:135-48; PMID:19150373; http://dx.doi.org/10.1016/j. brainresrev.2008.12.011
60. Zhuang ZY, Gerner P, Woolf CJ, Ji RR. ERK is sequentially activated in neurons, microglia, and astrocytes by spinal nerve ligation and contributes to mechanical allodynia in this neuropathic pain model. Pain 2005; 114:149-59; PMID:15733640; http://dx. doi.org/10.1016/j.pain.2004.12.022
61. Suo Z, Wu M, Citron BA, Gao C, Festoff BW. Persistent protease-activated receptor 4 signaling mediates thrombin-induced microglial activation. J Biol Chem 2003; 278:31177-83; PMID:12775717; http://dx. doi.org/10.1074/jbc.M302137200
62. Mizushima T, Obata K, Yamanaka H, Dai Y, Fukuoka T, Tokunaga A, Mashimo T, Noguchi K. Activation of p38 MAPK in primary afferent neurons by noxious stimulation and its involvement in the development of thermal hyperalgesia. Pain 2005; 113:51-60; PMID:15621364; http://dx.doi.org/ 10.1016/j.pain.2004.09.038
63. Caterina MJ, Schumacher MA, Tominaga M, Rosen TA, Levine JD, Julius D. The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature 1997; 389:816-24; PMID:9349813; http:// dx.doi.org/10.1038/39807
64. Zygmunt PM, Petersson J, Andersson DA, Chuang H, Sorgard M, Di Marzo V, Julius D, Högestätt ED. Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature 1999; 400:452-7; PMID:10440374; http://dx.doi.org/ 10.1038/22761
65. Szallasi A, Cruz F, Geppetti P. TRPV1: a therapeutic target for novel analgesic drugs? Trends Mol Med 2006; 12:545-54; PMID:16996800; http://dx.doi. org/10.1016/j.molmed.2006.09.001
66. Ghilardi JR, Rohrich H, Lindsay TH, Sevcik MA, Schwei MJ, Kubota K, Halvorson KG, Poblete J, Chaplan SR, Dubin AE, et al. Selective blockade of the capsaicin receptor TRPV1 attenuates bone cancer pain. J Neurosci 2005; 25:3126-31; PMID:15788769; http://dx.doi.org/10.1523/JNEUR OSCI.3815-04.2005
67. Jones RC 3rd, Xu L, Gebhart GF. The mechanosensitivity of mouse colon afferent fibers and their sensitization by inflammatory mediators require transient receptor potential vanilloid 1 and acid-sensing ion channel 3. J Neurosci 2005; 25:10981-9; PMID:16306411; http://dx.doi.org/10.1523/JNEUR OSCI.0703-05.2005
68. Keeble J, Russell F, Curtis B, Starr A, Pinter E, Brain SD. Involvement of transient receptor potential vanilloid 1 in the vascular and hyperalgesic components of joint inflammation. Arthritis Rheum 2005; 52:3248-56; PMID:16200599; http://dx.doi.org/10.1002/art.21297
69. Zhu WJ, Yamanaka H, Obata K, Dai Y, Kobayashi K, Kozai T, Tokunaga A, Noguchi K. Expression of mRNA for four subtypes of the proteinase-activated receptor in rat dorsal root ganglia. Brain Res 2005; 1041:205-11; PMID:15829229; http://dx.doi.org/ 10.1016/j.brainres.2005.02.018
70. Schnizler K, Shutov LP, Van KaneganMJ, MerrillMA, Nichols B, McKnight GS, Strack S, Hell JW, Usachev YM. Protein kinase A anchoring via AKAP150 is essential for TRPV1 modulation by forskolin and prostaglandin E2 in mouse sensory neurons. J Neurosci 2008; 28:4904-17; PMID:18463244; http://dx.doi.org/ 10.1523/JNEUROSCI.0233-08.2008
71. Mohapatra DP, Nau C. Regulation of Ca2+-dependent desensitization in the vanilloid receptor TRPV1 by calcineurin and cAMP-dependent protein kinase. J Biol Chem 2005; 280:13424-32; PMID:15691846; http://dx.doi.org/10.1074/jbc.M410917200
72. Nishimura S, Ishikura H, Matsunami M, Shinozaki Y, Sekiguchi F, Naruse M, Kitamura T, Akashi R, Matsumura K, Kawabata A. The proteinase/proteinaseactivated receptor-2/transient receptor potential vanil-loid-1 cascade impacts pancreatic pain in mice. Life sciences 2010; 87:643-50; PMID:20932849; http:// dx.doi.org/10.1016/j.lfs.2010.09.030
73. De Petrocellis L, Harrison S, Bisogno T, Tognetto M, Brandi I, Smith GD, Creminon C, Davis JB, Geppetti P, Di Marzo V. The vanilloid receptor (VR1)-mediated effects of anandamide are potently enhanced by the cAMP-dependent protein kinase. J Neurochem 2001; 77:1660-3; PMID:11413249; http://dx.doi. org/10.1046/j.1471-4159.2001.00406.x
74. Bhave G, Zhu W, Wang H, Brasier DJ, Oxford GS, Gereau RW 4th. cAMP-dependent protein kinase regulates desensitization of the capsaicin receptor (VR1) by direct phosphorylation. Neuron 2002; 35:721-31; PMID:12194871; http://dx.doi.org/10.1016/S0896-6273(02)00802-4
75. Rathee PK, Distler C, Obreja O, Neuhuber W, Wang GK, Wang SY, Nau C, Kress M. PKA/AKAP/VR-1 module: a common link of Gs-mediated signaling to thermal hyperalgesia. J Neurosci 2002; 22:4740-5; PMID:12040081
76. Means AR. Regulatory cascades involving calmodulindependent protein kinases. Mol Endocrinol 2000; 14:4-13; PMID:10628743
77. Mellstrom B, Savignac M, Gomez-Villafuertes R, Naranjo JR. Ca2+-operated transcriptional networks: molecular mechanisms and in vivo models. Physiol Rev 2008; 88:421-49; PMID:18391169; http://dx. doi.org/10.1152/physrev.00041.2005
78. Mayr B, Montminy M. Transcriptional regulation by the phosphorylation-dependent factor CREB. Nat Rev Mol Cell Biol 2001; 2:599-609; PMID:11483993; http://dx.doi.org/10.1038/ 35085068
79. Lonze BE, Ginty DD. Function and regulation of CREB family transcription factors in the nervous system. Neuron 2002; 35:605-23; PMID:12194863; http://dx.doi.org/10.1016/S0896-6273(02)00828-0
80. Tamura S, Morikawa Y, Senba E. Up-regulated phosphorylation of signal transducer and activator of transcription 3 and cyclic AMP-responsive element binding protein by peripheral inflammation in primary afferent neurons possibly through oncostatin M receptor. Neuroscience 2005; 133:797-806; PMID:15893881; http://dx.doi.org/10.1016/j. neuroscience.2005.02.046
81. Amadesi S, Cottrell GS, Divino L, Chapman K, Grady EF, Bautista F, Karanjia R, Barajas-Lopez C, Vanner S, Vergnolle N, et al. Protease-activated receptor 2 sensitizes TRPV1 by protein kinase Cepsi-lon-and A-dependent mechanisms in rats and mice. J Physiol 2006; 575:555-71; PMID:16793902; http:// dx.doi.org/10.1113/jphysiol.2006.111534
82. Nakanishi M, Hata K, Nagayama T, Sakurai T, Nishisho T, Wakabayashi H, Hiraga T, Ebisu S, Yoneda T. Acid activation of Trpv1 leads to an up-regulation of calcitonin gene-related peptide expression in dorsal root ganglion neurons via the CaMK-CREB cascade: a potential mechanism of inflammatory pain. Mol Biol Cell 2010; 21:2568-77; PMID:20534813; http://dx.doi.org/10.1091/mbc.E10-01-0049
83. Julius D, Basbaum AI. Molecular mechanisms of nociception. Nature 2001; 413:203-10; PMID:11557989; http://dx.doi.org/10.1038/35093019
84. Bhave G, Gereau RW 4th. Posttranslational mechanisms of peripheral sensitization. J Neurobiol 2004; 61: 88-106; PMID:15362155; http://dx.doi.org/ 10.1002/neu.20083
85. Liedtke W, Tobin DM, Bargmann CI, Friedman JM. Mammalian TRPV4 (VR-OAC) directs behavioral responses to osmotic and mechanical stimuli in Caenorhabditis elegans. Proc Natl Acad Sci U S A 2003; 100(Suppl 2):14531-6; PMID:14581619
86. Liedtke W, Choe Y, Marti-Renom MA, Bell AM, Denis CS, Sali A, Hudspeth AJ, Friedman JM, Heller S. Vanilloid receptor-related osmotically activated channel (VR-OAC), a candidate vertebrate osmoreceptor. Cell 2000; 103:525-35; PMID:11081638; http://dx.doi.org/10.1016/S0092-8674(00)00143-4
87. Guler AD, Lee H, Iida T, Shimizu I, Tominaga M, Caterina M. Heat-evoked activation of the ion channel, TRPV4. J Neurosci 2002; 22:6408-14; PMID:12151520
88. Pedersen S, Lambert IH, Thoroed SM, Hoffmann EK. Hypotonic cell swelling induces translocation of the alpha isoform of cytosolic phospholipase A2 but not the gamma isoform in Ehrlich ascites tumor cells. Eur J Biochem 2000; 267:5531-9; PMID:10951212
89. Watanabe H, Vriens J, Prenen J, Droogmans G, Voets T, Nilius B. Anandamide and arachidonic acid use epoxyeicosatrienoic acids to activate TRPV4 channels. Nature 2003; 424:434-8; PMID:12879072; http:// dx.doi.org/10.1038/nature01807
90. Liedtke W, Friedman JM. Abnormal osmotic regulation in trpv4-/- mice. Proc Natl Acad Sci U S A 2003; 100:13698-703.
91. Suzuki M, Mizuno A, Kodaira K, Imai M. Impaired pressure sensation in mice lacking TRPV4. J Biol Chem 2003; 278:22664-8; PMID:12692122; http:// dx.doi.org/10.1074/jbc.M302561200
92. Alessandri-Haber N, Yeh JJ, Boyd AE, Parada CA, Chen X, Reichling DB, Levine JD. Hypotonicity induces TRPV4-mediated nociception in rat. Neuron 2003; 39:497-511; PMID:12895423; http://dx.doi. org/10.1016/S0896-6273(03)00462-8
93. Alessandri-Haber N, Joseph E, Dina OA, Liedtke W, Levine JD. TRPV4 mediates pain-related behavior induced by mild hypertonic stimuli in the presence of inflammatory mediator. Pain 2005; 118:70-9; PMID:16213085; http://dx.doi.org/10.1016/j.pain. 2005.07.016
94. Vergnolle N, Cenac N, Altier C, Cellars L, Chapman K, Zamponi GW, Materazzi S, Nassini R, Liedtke W, Cattaruzza F, et al. A role for transient receptor potential vanilloid 4 in tonicity-induced neurogenic inflammation. Br J Pharmacol 2010; 159:1161-73; PMID:20136846; http://dx.doi.org/10.1111/j.1476-5381.2009.00590.x
95. Cenac N, Andrews CN, Holzhausen M, Chapman K, Cottrell G, Andrade-Gordon P, Steinhoff M, Barbara G, Beck P, Bunnett NW, et al. Role for protease activity in visceral pain in irritable bowel syndrome. J Clin Invest 2007; 117:636-47; PMID:17304351; http://dx.doi.org/10.1172/JCI29255
96. Grant AD, Cottrell GS, Amadesi S, Trevisani M, Nicoletti P, Materazzi S, Altier C, Cenac N, Zamponi GW, Bautista-Cruz F, et al. Protease-activated receptor 2 sensitizes the transient receptor potential vanilloid 4 ion channel to cause mechanical hyperalgesia in mice. J Physiol 2007; 578:715-33; PMID:17124270; http://dx.doi.org/10.1113/jphysiol.2006.121111
97. Sipe WE, Brierley SM, Martin CM, Phillis BD, Cruz FB, Grady EF, Liedtke W, Cohen DM, Vanner S, Blackshaw LA, et al. Transient receptor potential vanilloid 4 mediates protease activated receptor 2-induced sensitization of colonic afferent nerves and visceral hyperalgesia. Am J Physiol Gastroint Liver Physiol 2008; 294:G1288-98; PMID:18325985; http://dx.doi.org/10.1152/ajpgi.00002.2008
98. Watanabe H, Vriens J, Suh SH, Benham CD, Droogmans G, Nilius B. Heat-evoked activation of TRPV4 channels in a HEK293 cell expression system and in native mouse aorta endothelial cells. J Biol Chem 2002; 277:47044-51; PMID:12354759; http://dx. doi.org/10.1074/jbc.M208277200
99. Grant AD, Gerard NP, Brain SD. Evidence of a role for NK1 and CGRP receptors in mediating neurogenic vasodilatation in the mouse ear. Br J Pharmacol 2002; 135: 356-62; PMID:11815370; http://dx.doi. org/10.1038/sj.bjp.0704485
100. Rosenfeld MG, Mermod JJ, Amara SG, Swanson LW, Sawchenko PE, Rivier J, Vale WW, Evans RM. Production of a novel neuropeptide encoded by the calcitonin gene via tissue-specific RNA processing. Nature 1983; 304:129-35; PMID:6346105; http://dx.doi. org/10.1038/304129a0
101. Brain SD, Williams TJ. Inflammatory oedema induced by synergism between calcitonin gene-related peptide (CGRP) and mediators of increased vascular permeability. Br J Pharmacol 1985; 86:855-60; PMID:2416378; http://dx.doi.org/10.1111/j.1476-5381.1985.tb11107.x
102. McCulloch J, Uddman R, Kingman TA, Edvinsson L. Calcitonin gene-related peptide: functional role in cerebrovascular regulation. Proc Natl Acad Sci U S A 1986; 83:5731-5.
103. Tajti J, Kuris A, Vecsei L, Xu CB, Edvinsson L. Organ culture of the trigeminal ganglion induces enhanced expression of calcitonin gene-related peptide via activation of extracellular signal-regulated protein kinase 1/2. Cephalalgia 2011; 31:95-105; PMID:20851839; http://dx.doi.org/10.1177/0333102410382796
104. Lei L, Yuan X, Wang S, Zhang F, Han Y, Ning Q, Luo G, Lu S. Mitogen-activated protein kinase pathways are involved in the upregulation of calcitonin gene-related peptide of rat trigeminal ganglion after organ culture. J Mol Neurosci 2012; 48:53-65; PMID:22528462; http://dx.doi.org/10.1007/s12031-012-9772-y
105. Donnerer J, Liebmann I. Phosphorylation of ERK1/2 in dorsal root ganglia following sequential mustard oil and thermal stimulation of the rat hind paw. Pharmacology 2012; 89:7-12; PMID:22205121; http://dx. doi.org/10.1159/000334933
106. Hetman M, Gozdz A. Role of extracellular signal regulated kinases 1 and 2 in neuronal survival. Eur J Biochem 2004; 271:2050-5; PMID:15153093
107. Lanigan TM, Russo AF. Binding of upstream stimulatory factor and a cell-specific activator to the calcitonin/ calcitonin gene-related peptide enhancer. J Biol Chem 1997; 272:18316-24; PMID:9218472; http:// dx.doi.org/10.1074/jbc.272.29.18316
108. Bretschneider E, Kaufmann R, Braun M, Nowak G, Glusa E, Schror K. Evidence for functionally active protease-activated receptor-4 (PAR-4) in human vascular smooth muscle cells. Br J Pharmacol 2001; 132:1441-6; PMID:11264237; http://dx.doi.org/ 10.1038/sj.bjp.0703947
109. De Sousa LP, Brasil BS, Silva BM, Freitas MH, Nogueira SV, Ferreira PC, Kroon EG, Bonjardim CA. Plasminogen/plasmin regulates c-fos and egr-1 expression via the MEK/ERK pathway. Biochem Biophys Res Commun 2005; 329:237-45; PMID:15721299; http:// dx.doi.org/10.1016/j.bbrc.2005.01.123
110. Versteeg HH, Borensztajn KS, Kerver ME, Ruf W, Reitsma PH, Spek CA, Peppelenbosch MP. TF: FVIIa-specific activation of CREB upregulates proapoptotic proteins via protease-activated receptor-2. J Thromb Haemost 2008; 6:1550-7; PMID:18647225; http://dx.doi.org/10.1111/j.1538-7836.2008.03091.x
111. Wang H, Wen S, Bunnett NW, Leduc R, Hollenberg MD, MacNaughton WK. Proteinase-activated recep-tor-2 induces cyclooxygenase-2 expression through beta-catenin and cyclic AMP-response element-binding protein. J Biol Chem 2008; 283:809-15; PMID:17962194; http://dx.doi.org/10.1074/jbc. M703021200
112. Vergnolle N. Clinical relevance of proteinase activated receptors (pars) in the gut. Gut 2005; 54:867-74; PMID:15888798; http://dx.doi.org/10.1136/gut. 2004.048876
113. Vergnolle N. Postinflammatory visceral sensitivity and pain mechanisms. Neurogastroenterol Motil 2008; 20 (Suppl 1):73-80; PMID:18402644
114. Bradesi S. PAR4: a new role in the modulation of visceral nociception. Neurogastroenterol Motil 2009; 21:1129-32; PMID:19804483; http://dx.doi.org/ 10.1111/j.1365-2982.2009.01373.x
115. Slofstra SH, Bijlsma MF, Groot AP, Reitsma PH, Lindhout T, ten Cate H, Spek CA. Protease-activated receptor-4 inhibition protects from multiorgan failure in a murine model of systemic inflammation. Blood 2007; 110:3176-82; PMID:17641206; http://dx.doi. org/10.1182/blood-2007-02-075440
116. Proud D, Reynolds CJ, Lacapra S, Kagey-Sobotka A, Lichtenstein LM, Naclerio RM. Nasal provocation with bradykinin induces symptoms of rhinitis and a sore throat. Am Rev Respir Dis 1988; 137:613-6; PMID:3345041; http://dx.doi.org/10.1164/ajrccm/ 137.3.613
117. Asokananthan N, Graham PT, Fink J, Knight DA, Bakker AJ, McWilliam AS, Thompson PJ, Stewart GA. Activation of protease-activated receptor (PAR)-1, PAR-2, and PAR-4 stimulates IL-6, IL-8, and prostaglandin E2 release from human respiratory epithelial cells. J Immunol 2002; 168:3577-85; PMID:11907122; http://dx.doi.org/10.4049/jimmunol.168.7.3577
118. Russell FA, Veldhoen VE, Tchitchkan D, McDougall JJ. Proteinase-activated receptor-4 (PAR4) activation leads to sensitization of rat joint primary afferents via a bradykinin B2 receptor-dependent mechanism. J Neurophysiol 2010; 103:155-63; PMID:19889854; http://dx.doi.org/10.1152/jn.00486.2009
119. Hamilton JR, Frauman AG, Cocks TM. Increased expression of protease-activated receptor-2 (PAR2) and PAR4 in human coronary artery by inflammatory stimuli unveils endothelium-dependent relaxations to PAR2 and PAR4 agonists. Circul Res 2001; 89:92-8; PMID:11440983; http://dx.doi.org/10.1161/hh1301.092661
120. Ritchie E, Saka M, Mackenzie C, Drummond R, Wheeler-Jones C, Kanke T, Plevin R. Cytokine upregulation of proteinase-activated-receptors 2 and 4 expression mediated by p38MAP kinase and inhibitory kappa B kinase beta in human endothelial cells. Br J Pharmacol 2007; 150:1044-54; PMID:17339845; http://dx.doi. org/10.1038/sj.bjp.0707150